Cargando…

Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study

BACKGROUND: The incidence of cirrhosis for individuals in Sweden has previously been reported as stable/low among European countries. However, Swedish population-based studies are scarce and none of them included data from the most recent decade (2010–2019). We aimed to describe the incidence and ae...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaz, Juan, Eriksson, Berne, Strömberg, Ulf, Buchebner, David, Midlöv, Patrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118963/
https://www.ncbi.nlm.nih.gov/pubmed/32245414
http://dx.doi.org/10.1186/s12876-020-01239-6
_version_ 1783514675164479488
author Vaz, Juan
Eriksson, Berne
Strömberg, Ulf
Buchebner, David
Midlöv, Patrik
author_facet Vaz, Juan
Eriksson, Berne
Strömberg, Ulf
Buchebner, David
Midlöv, Patrik
author_sort Vaz, Juan
collection PubMed
description BACKGROUND: The incidence of cirrhosis for individuals in Sweden has previously been reported as stable/low among European countries. However, Swedish population-based studies are scarce and none of them included data from the most recent decade (2010–2019). We aimed to describe the incidence and aetiology of cirrhosis in the Halland region from 2011 to 2018, and to describe the severity and prevalence of liver-related complications and other primary comorbidities at the time of cirrhosis diagnosis. METHODS: We conducted a retrospective cohort study of all patients with cirrhosis in Halland, which has a population of 310,000 inhabitants. Medical records and histopathology registries were reviewed. RESULTS: A total of 598 patients with cirrhosis were identified. The age-standardised incidence was estimated at 23.2 per 100,000 person-years (95% CI 21.3–25.1), 30.5 (95% CI 27.5–33.8) for men and 16.4 (95% CI 14.3–18.7) for women. When stratified by age, the highest incidence rates were registered at age 60–69 years. Men had a higher incidence rate for most age groups when compared to women. The most common aetiology was alcohol (50.5%), followed by cryptogenic cirrhosis (14.5%), hepatitis C (13.4%), and non-alcoholic fatty liver disease (5.7%). Most patients had at least one liver-related complication at diagnosis (68%). The most common comorbidities at diagnosis were arterial hypertension (33%), type 2 diabetes (29%) and obesity (24%). CONCLUSIONS: Based on previous Swedish studies, our results indicate that the incidence of cirrhosis in Sweden might be considerably higher than previously reported. It is uncertain if the incidence of cirrhosis has previously been underestimated or if an actual increment has occurred during the course of the most recent decade. The increased incidence rates of cirrhosis reported in Halland are multifactorial and most likely related to higher incidence rates among the elderly. Pre-obesity and obesity are common in cirrhosis and non-alcoholic fatty liver disease has become an important cause of cirrhosis in Halland.
format Online
Article
Text
id pubmed-7118963
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71189632020-04-07 Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study Vaz, Juan Eriksson, Berne Strömberg, Ulf Buchebner, David Midlöv, Patrik BMC Gastroenterol Research Article BACKGROUND: The incidence of cirrhosis for individuals in Sweden has previously been reported as stable/low among European countries. However, Swedish population-based studies are scarce and none of them included data from the most recent decade (2010–2019). We aimed to describe the incidence and aetiology of cirrhosis in the Halland region from 2011 to 2018, and to describe the severity and prevalence of liver-related complications and other primary comorbidities at the time of cirrhosis diagnosis. METHODS: We conducted a retrospective cohort study of all patients with cirrhosis in Halland, which has a population of 310,000 inhabitants. Medical records and histopathology registries were reviewed. RESULTS: A total of 598 patients with cirrhosis were identified. The age-standardised incidence was estimated at 23.2 per 100,000 person-years (95% CI 21.3–25.1), 30.5 (95% CI 27.5–33.8) for men and 16.4 (95% CI 14.3–18.7) for women. When stratified by age, the highest incidence rates were registered at age 60–69 years. Men had a higher incidence rate for most age groups when compared to women. The most common aetiology was alcohol (50.5%), followed by cryptogenic cirrhosis (14.5%), hepatitis C (13.4%), and non-alcoholic fatty liver disease (5.7%). Most patients had at least one liver-related complication at diagnosis (68%). The most common comorbidities at diagnosis were arterial hypertension (33%), type 2 diabetes (29%) and obesity (24%). CONCLUSIONS: Based on previous Swedish studies, our results indicate that the incidence of cirrhosis in Sweden might be considerably higher than previously reported. It is uncertain if the incidence of cirrhosis has previously been underestimated or if an actual increment has occurred during the course of the most recent decade. The increased incidence rates of cirrhosis reported in Halland are multifactorial and most likely related to higher incidence rates among the elderly. Pre-obesity and obesity are common in cirrhosis and non-alcoholic fatty liver disease has become an important cause of cirrhosis in Halland. BioMed Central 2020-04-03 /pmc/articles/PMC7118963/ /pubmed/32245414 http://dx.doi.org/10.1186/s12876-020-01239-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Vaz, Juan
Eriksson, Berne
Strömberg, Ulf
Buchebner, David
Midlöv, Patrik
Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study
title Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study
title_full Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study
title_fullStr Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study
title_full_unstemmed Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study
title_short Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study
title_sort incidence, aetiology and related comorbidities of cirrhosis: a swedish population-based cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118963/
https://www.ncbi.nlm.nih.gov/pubmed/32245414
http://dx.doi.org/10.1186/s12876-020-01239-6
work_keys_str_mv AT vazjuan incidenceaetiologyandrelatedcomorbiditiesofcirrhosisaswedishpopulationbasedcohortstudy
AT erikssonberne incidenceaetiologyandrelatedcomorbiditiesofcirrhosisaswedishpopulationbasedcohortstudy
AT strombergulf incidenceaetiologyandrelatedcomorbiditiesofcirrhosisaswedishpopulationbasedcohortstudy
AT buchebnerdavid incidenceaetiologyandrelatedcomorbiditiesofcirrhosisaswedishpopulationbasedcohortstudy
AT midlovpatrik incidenceaetiologyandrelatedcomorbiditiesofcirrhosisaswedishpopulationbasedcohortstudy